207 related articles for article (PubMed ID: 8742444)
1. Association between clozapine response and allelic variation in the 5-HT2C receptor gene.
Sodhi MS; Arranz MJ; Curtis D; Ball DM; Sham P; Roberts GW; Price J; Collier DA; Kerwin RW
Neuroreport; 1995 Dec; 7(1):169-72. PubMed ID: 8742444
[TBL] [Abstract][Full Text] [Related]
2. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.
Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
Pharmacogenet Genomics; 2010 Apr; 20(4):274-6. PubMed ID: 20168265
[TBL] [Abstract][Full Text] [Related]
3. Clozapine response and the 5HT2C Cys23Ser polymorphism.
Malhotra AK; Goldman D; Ozaki N; Rooney W; Clifton A; Buchanan RW; Breier A; Pickar D
Neuroreport; 1996 Sep; 7(13):2100-2. PubMed ID: 8930967
[TBL] [Abstract][Full Text] [Related]
4. Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics.
Kohlrausch FB; Salatino-Oliveira A; Gama CS; Lobato MI; Belmonte-de-Abreu P; Hutz MH
J Psychiatr Res; 2010 Dec; 44(16):1158-62. PubMed ID: 20452607
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
[TBL] [Abstract][Full Text] [Related]
6. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.
Rietschel M; Naber D; Fimmers R; Möller HJ; Propping P; Nöthen MM
Neuroreport; 1997 May; 8(8):1999-2003. PubMed ID: 9223092
[TBL] [Abstract][Full Text] [Related]
9. Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia.
Zhang ZJ; Zhang XB; Sha WW; Zhang XB; Reynolds GP
Mol Psychiatry; 2002; 7(7):670-1. PubMed ID: 12192608
[No Abstract] [Full Text] [Related]
10. Association between clozapine response and allelic variation in 5-HT2A receptor gene.
Arranz M; Collier D; Sodhi M; Ball D; Roberts G; Price J; Sham P; Kerwin R
Lancet; 1995 Jul; 346(8970):281-2. PubMed ID: 7630250
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.
Arranz MJ; Collier DA; Munro J; Sham P; Kirov G; Sodhi M; Roberts G; Price J; Kerwin RW
Neurosci Lett; 1996 Oct; 217(2-3):177-8. PubMed ID: 8916101
[TBL] [Abstract][Full Text] [Related]
12. Predictors of clozapine response in schizophrenia.
Pickar D; Owen RR; Litman RE; Hsiao JK; Su TP
J Clin Psychiatry; 1994 Sep; 55 Suppl B():129-32. PubMed ID: 7525541
[TBL] [Abstract][Full Text] [Related]
13. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
14. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C).
Lappalainen J; Zhang L; Dean M; Oz M; Ozaki N; Yu DH; Virkkunen M; Weight F; Linnoila M; Goldman D
Genomics; 1995 May; 27(2):274-9. PubMed ID: 7557992
[TBL] [Abstract][Full Text] [Related]
15. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
Ewald HL; Mors NP; Rosenberg R
Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
[TBL] [Abstract][Full Text] [Related]
16. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.
Masellis M; Basile VS; Meltzer HY; Lieberman JA; Sevy S; Goldman DA; Hamblin MW; Macciardi FM; Kennedy JL
Schizophr Res; 2001 Jan; 47(1):49-58. PubMed ID: 11163544
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.
Malhotra AK; Goldman D; Ozaki N; Breier A; Buchanan R; Pickar D
Am J Psychiatry; 1996 Aug; 153(8):1092-4. PubMed ID: 8678181
[TBL] [Abstract][Full Text] [Related]
20. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
